Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 5/20 | 0.37 |
| ▸ | MMP3 | P08254 | 5/20 | 0.37 |
| ▸ | GBA1 | P04062 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | GRM5 | P41594 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.32 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1092477 | 0.90 | MMP1 (0.40) | MMP1MMP3GBA1ALDH1A1KAT2B | |
| SCHEMBL5573150 | 0.82 | SMN1; SMN2 (0.36) | MMP1MMP3NPC1RAB9A | |
| SCHEMBL26761122 | 0.80 | PIK3CD (0.53) | MMP1MMP3ALDH1A1PIK3CD | |
| SCHEMBL4989478 | 0.79 | ALDH1A1 (0.36) | MMP1MMP3GBA1ALDH1A1NPC1 | |
| SCHEMBL2687128 | 0.79 | DPP4 (0.42) | MMP1MMP3GBA1ALDH1A1NPC1 | |
| SCHEMBL24471008 | 0.77 | PIK3CD (0.39) | MMP1MMP3ALDH1A1PIK3CDHRH3 | |
| SCHEMBL26789326 | 0.77 | PER2 (0.37) | MMP1MMP3GBA1ALDH1A1PIK3CD | |
| SCHEMBL24485369 | 0.77 | MMP1 (0.34) | MMP1MMP3GBA1ALDH1A1PIK3CD | |
| SCHEMBL16859438 | 0.76 | ACE (0.36) | ALDH1A1PIK3CD | |
| SCHEMBL1092141 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8961946-B2 | Hair processing agent and method for permanent waving hair | SHOWA DENKO K.K. (JP) | 2015-02-24 | — | — | US | claimed |
| EP-2024330-B1 | PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND | SHOWA DENKO KK (JP) | 2012-04-25 | — | — | EP | claimed |
| US-7902383-B2 | Production method of heterocyclic mercapto compound | SHOWA DENKO K.K. (JP) | 2011-03-08 | — | — | US | claimed |
| EP-1896139-B1 | PERMANENT WAVING AND SIMULTANEOUSLY COLORING AGENT | SHOWA DENKO KK (JP) | 2010-03-31 | — | — | EP | claimed |
| US-20090171095-A1 | PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND | SHOWA DENKO K.K. (JP) | 2009-07-02 | — | — | US | claimed |
| US-20090081147-A1 | PERMANENT WAVING AGENT | SHOWA DENKO K.K. (JP) | 2009-03-26 | — | — | US | claimed |
| EP-2024330-A1 | PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND | Showa Denko K.K. (JP) | 2009-02-18 | — | — | EP | claimed |
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | RESONAC CORPORATION (JP) | 2008-04-10 | — | — | US | claimed |
| EP-1896139-A2 | PERMANENT WAVING AND SIMULTANEOUSLY COLORING AGENT | Showa Denko K.K. (JP) | 2008-03-12 | — | — | EP | claimed |
| WO-2007139215-A1 | PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND | SHOWA DENKO K.K. (JP) | 2007-12-06 | — | — | WO | claimed |
| EP-1827370-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | Showa Denko K.K. (JP) | 2007-09-05 | — | — | EP | claimed |
| WO-2006121214-A2 | PERMANENT WAVING AND SIMULTANEOUSLY COLORING AGENT | SHOWA DENKO K.K. (JP) | 2006-11-16 | — | — | WO | claimed |
| WO-2006068276-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | SHOWA DENKO K.K. (JP) | 2006-06-29 | — | — | WO | claimed |
| CN-113848681-B | Photosensitive resin composition, dry film and cured film thereof, and printed wiring board using the same | 太阳控股株式会社 | 2024-09-03 | — | — | CN | disclosed |
| WO-2022211082-A1 | PHOTOSENSITIVE FILM LAMINATED BODY, CURED PRODUCT, AND PRINTED CIRCUIT BOARD | 太陽インキ製造株式会社 | 2022-10-06 | — | — | WO | disclosed |
| CN-113848681-A | Photosensitive resin composition, dry film and cured coating film thereof, and printed wiring board using same | 太阳油墨制造株式会社 | 2021-12-28 | — | — | CN | disclosed |
| WO-2007139215-A1 | PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND | SHOWA DENKO K.K. (JP) | 2007-12-06 | — | — | WO | disclosed |
| EP-1827370-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | Showa Denko K.K. (JP) | 2007-09-05 | — | — | EP | disclosed |
| WO-2006121214-A2 | PERMANENT WAVING AND SIMULTANEOUSLY COLORING AGENT | SHOWA DENKO K.K. (JP) | 2006-11-16 | — | — | WO | disclosed |
| WO-2006068276-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | SHOWA DENKO K.K. (JP) | 2006-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090081147-A1 | PERMANENT WAVING AGENT | SULT2A1, SULT1A1, CYP2F1 | MMP1 1476/4885MMP3 2833/4885GBA1 4743/4885 |
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | TST, CYSLTR1, CYSLTR2 | MMP1 1243/4885MMP3 3627/4885GBA1 2183/4885 |
| US-20090171095-A1 | PRODUCTION METHOD OF HETEROCYCLIC MERCAPTO COMPOUND | POR, SULT2A1, CYP2E1 | MMP1 1782/4885MMP3 3853/4885GBA1 4289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.